Final Program

240 TUESDAY • MAY 17
bronchiectasis that may cause end-stage lung disease by adulthood. This
session will highlight new insights into pathomechanisms of disease that have
come from both model systems and human gene discovery studies, as well as
clinical insights that have arisen from multi-center efforts in North America and
Europe to study PCD cohorts over the past decade. Clinical insights will include
genotype-phenotype associations, new diagnostic tests and an update on
clinical trials that are currently being conducted around the world.
Chairing: S.D.M. Dell, MD, Toronto, Canada
T.W. Ferkol, MD, St. Louis, MO
9:00 A Patient’s Perspective
M. Kitlowski, Baltimore, MD
R. Giannokos, Silver Spring, MD
9:05 Mechanisms of Ciliary Assembly Defects in PCD
S. Brody, MD, St. Louis, MO
9:30 Phenotype-Genotype Relationships in Children and Adults
S. Davis, MD, Indianapolis, IN
9:50 Incorporating Emerging Genetic Testing into Diagnostic
Strategies
M. Leigh, MD, Chapel Hill, NC
10:10 Airway Microbiology and Inflammation in PCD
K.N. Olivier, MD, MPH, Bethesda, MD
10:30 The Impact of Disease Management Strategies on Long-Term
Prognosis
J. Lucas, PhD, Southampton, United Kingdom
C10
There will be a 5-minute discussion after each talk.
BEHAVIORAL • CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
ACHIEVING “ENVIRONMENTAL JUSTICE”: A
MAJOR STEP TOWARD RESPIRATORY HEALTH
EQUALITY
Assemblies on Environmental, Occupational and Population Health;
Allergy, Immunology and Inflammation; Behavioral Science and Health
Services Research; Clinical Problems; Critical Care; Microbiology,
Tuberculosis and Pulmonary Infections; Nursing; Pediatrics; Sleep and
Respiratory Neurobiology; Health Equality Sub-Committee
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2002/2004 (West Building, Level 2)
Target Audience
Clinicians, researchers and public health practitioners focusing on the
prevention and treatment of respiratory diseases.
Objectives
At the conclusion of this session, the participant will be able to:
• learn new findings about the impact of major environmental risk factors on
respiratory health disparities;
• apply new strategies to advocate for environmental justice as means to achieve
respiratory health equality;
• discuss feasible and necessary policies to achieve environmental justice and thus
move toward respiratory health equality.
Because the frequency of major environmental risk factors for respiratory diseases differs
across demographic groups (defined by socioeconomic status, race/ethnicity, sexual
orientation, health care access, occupation, or other characteristics), respiratory health
disparities are commonly encountered in pediatric and adult pulmonary medicine.
Attainment of respiratory health equality requires the ending of respiratory health
disparities, which can be achieved only through multidisciplinary efforts to eliminate
detrimental environmental exposures. This symposium will review and discuss the current
challenges posed by key environmental risk factors for health disparities (smoking, air
pollution and occupation), focusing on knowledge gaps and health policy needs.
Chairing: J.C. Celedon, MD, DrPH, Pittsburgh, PA
J.M. Samet, MD, MS, Los Angeles, CA
E.G. Burchard, MD, MPH, San Francisco, CA
9:00 Environmental Justice and Health Equality: Conceptual
Framework
J.C. Celedon, MD, DrPH, Pittsburgh, PA
9:20 Tobacco Use and Respiratory Health Disparities
P. Ling, MD, San Francisco, CA
9:40 Traffic-Related Air Pollution: Who Lives Closer to Major
Highways?
J.R. Balmes, MD, San Francisco, CA
10:00 Countering Targeted Campaigns Against Vulnerable
Populations: Menthol Cigarettes as a Case Study
E.R. Neptune, MD, Baltimore, MD
10:20 Not All Occupations Are Equal: Migrant Workers as a Case
Study
M.B. Schenker, MD, MPH, Davis, CA
10:40 Short and Long Term Policies to Achieve Environmental
Justice
M.B. Rice, MD, MPH, Boston, MA
C11
BASIC • CLINICAL • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
PATHOGENESIS AND TREATMENT OF
OBSTRUCTIVE LUNG DISEASES: NEW INSIGHTS
Assemblies on Respiratory Structure and Function; Allergy, Immunology
and Inflammation; Microbiology, Tuberculosis and Pulmonary Infections;
Respiratory Cell and Molecular Biology
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 2006/2008 (West Building, Level 2)
Target Audience
Allergists, pulmonologists, basic scientists, physiologists, translational
researchers, fellows and residents, and graduate trainees interested in the
pathophysiology and emerging treatment options for obstructive lung diseases.
Objectives
At the conclusion of this session, the participant will be able to:
• describe factors contributing to the onset and progression of obstructive lung
diseases;
ATS 2016 • San Francisco